Gustavo Heresi, MD

Appointed
2008

Education & Fellowships

Graduate School - Case Western Reserve
Clinical Research
Cleveland, OH USA
2017

Fellowship - Cleveland Clinic
Pulmonary / Critical Care
Cleveland, OH USA
2008

Residency - Jackson Memorial Hospital
Internal Medicine
Miami, FL USA
2005

Medical Education - Universidad Nacional de San Agustin Facultad de Medicina
Arequipa,
2000

Additional Training

• Master of Science in Clinical Research Program at Case Western Reserve University

Professional Highlights

• CTEPH Subcommittee of PHA's Early Diagnosis Campaign

  Member2014 – Present

• American Thoracic Society Assembly on Pulmonary Circulation Program Committee

  Member2015 – present

• Editorial Board member for CTEPH.com.

  Member 2014 – Present

• Writing Committee of the ISHLT Consensus Document titled“Consensus Statement: The Evaluation and Management of Patients with Chronic Thromboembolic Pulmonary Hypertension”

  Member2017

• Pulmonary Embolism Response Team (PERT) Consortium Research Committee

  Co-Chair 2018

• PHA Scientific Leadership Council CTEPH Working Group

  Member May 2018 - Present

Certifications

• Internal Medicine - Pulmonary Disease
• Internal Medicine - Critical Care Medicine

Specialty Interests

Pulmonary hypertension, chronic thromboembolic pulmonary hypertension (CTEPH), acute pulmonary embolism, acute respiratory distress syndrome (ARDS), sepsis Acute respiratory distress syndrome (ARDS), pneumonia, pulmonary fibrosis, pulmonary hypertension, scleroderma, sepsis, Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Acute respiratory distress syndrome (ARDS), pneumonia, pulmonary fibrosis, pulmonary hypertension, scleroderma, sepsis

Awards & Honors

• Gilead Sciences Research Scholars Program Award in Pulmonary Arterial Hypertension 2009
• Listed in Who's Who in America 2009
• Listed in Best Doctors in America 2012
• Young Investigator Award, American College of Chest Physicians 2012
• Teacher of the Year Award, Cleveland Clinic Pulmonary/Critical Care Fellowship Program 2013-2014

Memberships

• American Thoracic Society
• American College of Chest Physicians
• Society of Critical Care Medicine
• Pulmonary Hypertension Association
• International CTEPH Association
• International Society of Heart and Lung Transplantation

See publications for Gustavo Heresi, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 3/1/2023, Dr. Heresi has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Heresi receives fees of $5,000 or more per year (or, in rare cases, equity or stock options) as a paid consultant, speaker or as a member of an advisory committee for the following companies:

• Janssen Pharmaceuticals, Inc.
• Bayer Healthcare Pharmaceuticals, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.